Wednesday, February 23, 2022

Cannabis and the law

 The WSJ has this update:

Push to Relax Marijuana Laws Hits Roadblocks. Biden administration has sidestepped the issue of decriminalizing cannabis despite bipartisan support.  By Alex Leary

"Facing a tough midterm election and divisions in Congress, the Biden administration is sidestepping the politically sensitive issue of loosening marijuana laws even as the idea has gained support of most Americans.

"More than half of U.S. states have legalized cannabis use for some purposes. Lawmakers have proposed decriminalizing marijuana, which would entail reduced penalties for users, and have pushed for giving the industry access to banking services. Those promoting changes include a diverse range of political figures, from former Republican House Speaker John Boehner to progressive Rep. Alexandria Ocasio-Cortez (D., N.Y.).

...

"More than two in three Americans support legalizing marijuana, according to a 2021 Gallup poll. That is up from a decade ago, when half of Americans were in favor, Gallup found.

...

"The House has previously passed legislation to decriminalize it and this month approved provisions to give cannabis companies access to the banking system, as marijuana lobbying has soared in what has become a multibillion-dollar industry.

"But with many Republicans and some Democrats opposed, odds of Senate passage are slim given filibuster rules requiring 60 votes."

Tuesday, February 22, 2022

California State Assembly bill would reimburse living donor expenses

 Here's some news about CA's newly proposed bill to reimburse living organ donor expenses.

American Kidney Fund Applauds Introduction of California Living Organ Donor Reimbursement Act. If passed, AB 2504 would be the first law of its kind in the nation

"The American Kidney Fund (AKF) strongly supports the introduction of the Living Organ Donor Reimbursement Act (AB 2504) in the California State Assembly. The Living Organ Donor Reimbursement Act is a groundbreaking piece of legislation that would provide direct reimbursements of up to $10,000 to living organ donors for expenses associated with organ donation not covered by insurance. The bill would be the first of its kind enacted in the nation and would greatly remove financial barriers that currently prevent potential living organ donors from making their lifesaving gift.

"AKF has been working closely with the bill’s sponsor, Assemblymember Ash Kalra (District 27), to craft this legislation and introduce it in the State Assembly. According to AKF’s Living Donor Protection Report Card, 20 states currently reimburse living donors through tax credits or deductions, which help to remove financial barriers but are not nearly as inclusive as direct reimbursements. If this bill is enacted, California would be the first state to provide direct reimbursements to donors after surgery through the establishment of a Living Organ Donor Reimbursement Program in the State Department of Health Care Services."

***************

And here's the proposed bill:

ASSEMBLY BILL NO. 2504  Introduced by Assembly Member Kalra, (Coauthors: Assembly Members Bennett, Cristina Garcia, and Mullin), February 17, 2022

"Existing law, the Michelle Maykin Memorial Donation Protection Act, requires an employer to grant an employee an unpaid leave of absence, as specified, for the purpose of organ donation.

"Existing law establishes the State Department of Health Care Services within the California Health and Human Services Agency. Existing law sets forth the department’s powers and duties relating to, among other things, public health, licensing and certification of certain health facilities, and the state Medi-Cal program.

"This bill, the Living Organ Donor Reimbursement Act, would establish the Living Organ Donor Reimbursement Program in the State Department of Health Care Services to reduce financial barriers for living organ donors. The bill would authorize living organ donors, as defined, to apply to the department for reimbursement of qualified donation expenses, as defined, that were not, or will not, otherwise be reimbursed, including travel and lodging expenses, lost wages, child care costs, and medication costs. The bill would limit the total reimbursement costs awarded to each living organ donor to $10,000 per organ donation. The bill would create the Living Organ Donor Reimbursement Fund within the State Treasury. The bill would authorize the Controller to accept donations to the fund from private entities, and would continuously appropriate these moneys for purposes of the program. The bill would require the Controller to allocate other moneys in the fund, upon appropriation by the Legislature, for purposes of the program. The bill would repeal the provisions of the bill on January 1, 2027."

Monday, February 21, 2022

Kidney Transplant Collaborative

 The Kidney Transplant Collaborative has a new grants program, that includes the following exciting initiatives:

1. Kentucky Organ Donor Affiliates

Grant Project:  Pulsatile Perfusion from Procurement to Delivery at Accepting Centers 

Project Team:    David Dwyer, Transplant Center Liaison; Brian Roe, Chief Financial Officer; Jennifer Daniel, Organ Operations Director


2. Stanford University in collaboration with the Massachusetts Institute of Technology (MIT)

Grant Project:  Using Machine Learning to Improve Utilization and Reducing Discards in Deceased Donor Organ Allocation 

Project Team:  Itai Ashlagi, Associate Professor – Stanford; Paulo Somaini, Assistant Professor of Economics – Stanford; Nikhil Agarwal, Associate Professor of Economics – MIT


3. HonorBridge 

Grant Project:   Kidney Transplant in Rapid Organ Recovery from Donation after Uncontrolled Circulatory Death Donors 

Project Team:   Kimberly Koontz, Chief Operating Officer; Nissa Casey, Manager of Recovery Services; Joel Baucom, Director of Organ Operations; Lora Smitherman, Manager of Hospital Services


4. Columbia University in collaboration with the Cleveland Clinic and the National Kidney Foundation 

Grant Project:   Using Shared Decision Making to Improve Kidney Transplantation Rates 

Project Team:  Sumit Mohan, Associate Professor of Medicine and Epidemiology – Columbia University; Syed Ali Husain, Assistant Professor of Medicine – Columbia University; Kristin King, Data Analyst - Columbia University;  Anne Huml, Assistant Professor of Medicine – Cleveland Clinic; Jesse Schold, Director of Outcomes Research in Kidney Transplantation - Cleveland Clinic;  Peter Reese, Associate Professor of Medicine - University of Pennsylvania 


5. Cambridge85, LLC 

Grant Project:   Deceased Donor Kidney Chains 

Project Team:  Simon Keith, Founder/Principal ,Cambridge 85; Kelly Ranum, CEO, Louisiana Organ Procurement Organization; Diane Brockmeier, CEO, Mid-American Transplant; Kyle Herbert, CEO

Live on Nebraska;  Matt Wadsworth, CEO, Life Connection of Ohio


Sunday, February 20, 2022

2022 ESA World Meetings

 2022 Economic Science Association (ESA*) World Meetings  at MIT,  June 13-16

The 2022 World Economic Science Association Conference will be held at the Massachusetts Institute of Technology Sloan School of Management.

The Main ESA Conference will take place from Monday evening, June 13 (welcome reception) through Thursday, June 16, 2022. 

The Eighth Biennial Meeting of the Social Dilemmas Working Group will take place on Friday and Saturday, June 17 and 18, 2022.

Keynote speakers:

Lorenz Goette National University of Singapore and  University of Bonn 

Brit Grosskopf University of Exeter

Amanda Pallais Harvard University

Deadline for abstract submissions: March 14, 2022

*************

The Economic Science Association isn't the only ESA having a meeting in 2022. But if you are looking for one of these others you aren't yet in the right place:

2022 Annual Meeting - Ecological Society of America



Saturday, February 19, 2022

The Einstein Foundation Award for Promoting Quality in Research, call for nominations

 April 10 is the deadline for new nominations for the 2022 awards. (Some nominations from last year will be held over for consideration this year.

The Einstein Foundation Award for Promoting Quality in Research

Here's my post regarding the 2021 awards:

Thursday, November 25, 2021

Friday, February 18, 2022

The Economic Theory Conference in Memory and Honor of Hugo Sonnenschein, April 29-30, U. Chicago

 In April, a memorial conference honoring Hugo Sonnenschein:

The Economic Theory Conference in Memory and Honor of Hugo Sonnenschein

Date: Friday, April 29 to Saturday, April 30

Friday, April 29, 2022
8:00 am - 8:45 am
Continental Breakfast and Registration
8:45 am - 9:00 am
Introductory Remarks
Session 1
9:00 am - 9:45 am
General Equilibrium with Climate Change
9:45 am - 10:30 am
Market Design and Walrasian Equilibrium
10:30 am - 11:00 am
Break
Session 2
11:00 am - 11:45 am
Predicting Choice from Information Costs
11:45 am - 12:30 pm
Investment Incentives in Near-Optimal Mechanisms
12:30 pm - 2:00 pm
Lunch

With remarks by Dilip Abreu, New Yok University; Pierre-Andre Chiappori, Columbia University; Vijay Krishna, Pennsylvania State University; andJohn Roberts, Stanford University

 

Session 3
2:00 pm - 2:45 pm
2:45 pm - 3:30 pm
On the Structure of Informationally Robust Optimal Auctions
3:30 pm - 4:00 pm
Break
Session 4
4:00 pm - 4:45 pm
A Minskyite Model of Financial Crises
4:45 pm - 5:30 pm
5:30 pm
Conference Dinner

With remarks by Salvador Barberà, Universitat Autònoma de Barcelona; Matthew O. Jackson, Stanford University; David M. Kreps, Stanford University; and Robert Wilson, Stanford University

Location: City View Room, 10th Floor Rubenstein Forum

Saturday, April 30, 2022
8:00 am - 9:00 am
Continental Breakfast
Session 1
9:00 am - 9:45 am
Interactions Across Multiple Games: Implications for Cooperation, Corruption, and the Design of Teams and Organizations
9:45 am - 10:30 am
Efficiency in Random Resource Allocation and Social Choice
10:30 am - 11:00 am
Break
Session 2
11:00 am - 11:45 am
11:45 am - 12:30 pm
Bargaining with Exclusionary Commitments
**************

Thursday, July 15, 2021

Thursday, February 17, 2022

Mathematics and Computer Science of Market and Mechanism Design at MSRI Berkeley in Fall of 2023

 Here's an early announcement of a program at Berkeley's Mathematical Sciences Research Institute (MSRI). MSRI loves company, so if you have a sabbatical coming up and are interested in market design, this is worth looking into.

Mathematics and Computer Science of Market and Mechanism Design

August 21, 2023 to December 20, 2023

Organizers

Michal Feldman (Tel-Aviv University), Nicole Immorlica (Microsoft Research), LEAD Scott Kominers (Harvard University), Shengwu Li (Harvard University), Paul Milgrom (Stanford University), Alvin Roth (Stanford University), Tim Roughgarden (Stanford University), Eva Tardos (Cornell University)

Description

In recent years, economists and computer scientists have collaborated with mathematicians, operations research experts, and practitioners to improve the design and operations of real-world marketplaces. Such work relies on robust feedback between theory and practice, inspiring new mathematics closely linked – and directly applicable – to market and mechanism design questions. This cross-disciplinary program seeks to expand the domains in which existing market design solutions can be applied; address foundational questions regarding our ways of developing and evaluating mechanisms; and build useful analytic frameworks for applying theory to practical marketplace design. 

Wednesday, February 16, 2022

The Art Mart

 Art galleries are (among other things) middlemen, intermediating between artists and buyers of art, who may range from passionate consumers to institutional investors. (There are of course also passionate consumers who are also investors in an asset class that, like real estate, you can enjoy while it appreciates.)  

Of course, the galleries' incentives may not always be perfectly aligned with those of creators and consumers.  Galleries play a big role in helping bring young artists to market, and matching them to consumers and investors.  But as artists become more well known, other opportunities present themselves.

Here's a story from the WSJ about tensions involving sales by galleries versus sales by auction.

Why Artwork Flipping Can Incur the Wrath of Dealers. Dealers want to control the artists’ narrative and pricing, but investors want to leave it to the market  By Daniel Grant

"Chicago gallery owner Rhona Hoffman has three or four collectors she won’t sell to again.

“They broke the rule,” says the contemporary art dealer.

"That commandment to collectors: If you later decide to sell your artwork, consign it back to the gallery—do not put it up at auction.

"When buyers ignore this rule and auction off recently purchased pieces, it’s called flipping."

**********

Here's an older story, from Artsy, about the British artist/entrepreneur Damien Hirst, who has a long history of ambivalence about the role of galleries in the design of the market for art.

How Damien Hirst’s $200 Million Auction Became a Symbol of Pre-Recession Decadence by Nate Freeman

"On September 15, 2008, Sotheby’s was set to auction off 223 brand new works by Damien Hirst, including top-flight examples of his whole animals in formaldehyde, medicine cabinets, and spin paintings. It was an unprecedented incursion by an auction house into the primary market, and an unabashedly flashy sale accompanied by a global marketing tour with stops in Kiev, Aspen, and New Delhi.

...

"The Hirst auction, which the artist had dubbed “Beautiful Inside My Head Forever,” exceeded all expectations, grossing $200.75 million over the course of two sales in the span of 24 hours and becoming the most expensive single-artist auction ever. The 56 lots at the evening sale went 97% sold, and the two lots that did not find buyers during the auction were sold before the night was over. Over a third of the buyers had never bought contemporary art before. On the cusp of a global recession, Hirst walked away with $172 million.

...

"Taking work directly to market through an auction house would siphon millions of dollars from Hirst’s powerful dealers, Jay Jopling and Larry Gagosian. Hirst’s set up was typical of any in-demand artist at the time: He made work, and his dealers decided where to place it. Ordinarily, it is frowned upon when a vetted collector flips a work at auction. But Damien embraced that very act of betrayal and decided to pre-flip his own works to whoever could pay, with the support of Dunphy, whom he trusted more than his two dealers.

“Frank has my best interests at heart,” Hirst told The Economist in a story published before the sale. “Dealers say they do, but they don’t.”

Tuesday, February 15, 2022

The market for ballet dancers, by Olivia Hartzell

 Here's a post about the market for ballet dancers, by Olivia Hartzell, an econ Ph.D. student at Harvard whose previous profession was ballet. She writes in Dance Magazine that the market for dancers isn't as thick as it might be, because there aren't uniform times at which companies hire, and efficient matches are hard to predict. She proposes a centralized clearinghouse, but anticipates some obstacles to adoption and implementation.

The Ballet Job Market Needs a Market (Re)Design  by Olivia Hartzell

"The ballet job market is what an economist would refer to as a “matching market”—you cannot simply choose where to go, but you must also be chosen. What makes the ballet market peculiar is that, unlike most professional athletic markets, directors have vastly different preferences for dancers and they mostly do not (and cannot) compete for hires with salaries. Rather, dancers are first and foremost committed to finding their best artistic fits and are often willing to work for less than their worth.

This phenomenon would not be quite as problematic if dancers and directors were nonetheless matched efficiently. Unfortunately, there are two major failures that plague the current system.

First, although many, but not all, major ballet companies in the U.S. operate under the dancers’ union AGMA, there is virtually no regulation in terms of hiring. Deadlines to hold auditions, renew or cancel contracts are company-specific and are not standardized industry-wide. This is problematic because when streams of dancers are released into the audition market at different times, both companies and dancers can end up with undesirable results.

...

"In other settings, centralized clearinghouses have been enormously effective in eliminating similar market failures. Specifically, what I have in mind is a variant that I’ve designed of the well-known top trading cycles algorithm. It would work something like this: After all company departures have been announced and auditions held, dancers and directors would simply submit their preferences to a centralized algorithm that would quickly determine final assignments based on those preferences. 

...

"Of course, centralized clearinghouses are most effective when the majority of the market agrees to partake in them. While leaders may fear that this would require them to relinquish some control, they would only make offers to the dancers who they would under the best possible scenario, and the gains they would achieve by thickening and coordinating the market would far outweigh any perceived losses.

"As new leaders begin to take the reins at companies around the globe, time will tell whether they will be brave enough to challenge the status quo and reshape the marketplace in a way that truly works for both dancers and directors."

HT: Scott Kominers

*************

The market for ballet dancers is tough in other ways as well, e.g. it's the rare dancer who finds her way to graduate school later. Many professional dancers never go to college. See e.g. (also in Dance Magazine)

What Directors Really Think of Ballet Dancers Going To College by Sarah Wroth

"In the ballet world, the phrase “going to college” is sometimes regarded as the musings of a dancer who’s not really serious about their craft. Although schools like Juilliard and Bennington College have made degrees acceptable for modern dancers for decades, the competitive ballet world (which often follows a philosophy of “the younger the better”) tends to discourage higher education."

***************

And this, from a story about a dancer with an unusually long and storied career who was able to make a post ballet career in contemporary dance:

When Ballet Is Your Life, What Does Life After Ballet Look Like? Wendy Whelan only ever wanted to dance. But what happens when you can't dance anymore?  by Chloe Angyal

 "Career paths out of ballet are notoriously narrow. Dancers usually skip college, and even the end of high school, to devote themselves to dancing in their late teens and early 20s, which means that when they retire from dancing, they’re out in the job market without an entry-level degree. Some dancers go on to teach or coach, and some to choreograph, though the latter path is often even less stable, predictable or lucrative than being a dancer. Some go into ballet-adjacent work, like dance photography. Some will be picked to run companies; Pacific Northwest Ballet, Miami City Ballet, Washington Ballet and Pennsylvania Ballet are all run by alumni of the New York City Ballet or American Ballet Theater. But there are only so many ballet companies to run, and turnover at the top can be infrequent."

Monday, February 14, 2022

Building capacity in science

 Here's a post from Nature about some of the projects highlighted by the recent Einstein Foundation awards for promoting quality in research


Science Should Value Building Research Capacity

T
The Source
Written by Patrick S. Forscher and Moreen Terer

Science values outstanding, already-completed scientific achievements and the people who make them. This priority is illustrated in the profusion of scientific awards, such the Nobel Prize, Fields Medal, and Breakthrough Prize, that reward these accomplishments. However, science places less emphasis on efforts to promote quality within the research ecosystem itself. Nor does science typically recognize the critical capacity-building activities that are necessary to create the robust scientific ecosystems necessary to produce high quality research in the first place.


On November 21, 2021, the Einstein Foundation broke with this trend by issuing a series of awards for efforts to promote quality within the research ecosystem itself. Even more unusually, one of its award categories, the Early Career category, recognized not past achievements but rather outstanding proposed projects that showed special promise in promoting future quality. Four projects were shortlisted for this €100,000 award.

The projects that were shortlisted for the Early Career award shared something in common that may be unexpected: they are unusually focused on building a strong scientific community, especially in groups and settings that science has neglected. Take the first author’s (Patrick Forscher’s) project, for example. This project aimed to grow behavioral science in Africa by building a website, called “Lab in a Box”, to make it easy to set up a new behavioral lab in Africa, enhancing an existing database of measures with existing measures that are adapted to African languages and contexts, and stocking that database with newly translated and adapted measures. These activities are feasible due to Patrick’s position at a research center, the Busara Center for Behavioral Economics, that is both headquartered in Africa and dedicated to advancing behavioral science in the Global South. As Africa currently produces 2% of all research output (Kasprowicz et al., 2020), capacity-building activities such as the ones proposed are critical if behavioral science is to establish a robust presence in Africa.

***********

Capacity building is important in medicine as well as in science.  Here's a paper on global chains of kidney exchange, that would contribute to building surgical capacity around the world.

Global kidney chains, by Afshin Nikzad, Mohammad Akbarpour, Michael A. Rees, Alvin E. Roth, Proceedings of the National Academy of Sciences Sep 2021, 118 (36) e2106652118; DOI: 10.1073/pnas.2106652118

Sunday, February 13, 2022

The future pandemic that has already started making an appearance

I never expected the Covid pandemic: I was expecting a different one, coming not from a virus but from an antibiotic-resistant bacteria.  That one is still in our future, but here's an article that indicates that there are many bacterial candidates that could start something big, and taken together they are already starting to loom on the horizon.

In the Lancet (Available online 19 January 2022, In Press, Corrected Proof):

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis  By the  Antimicrobial Resistance Collaborators 

"Background: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen–drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date.

...

"Findings: On the basis of our predictive statistical models, there were an estimated 4·95 million (3·62–6·57) deaths associated with bacterial AMR in 2019, including 1·27 million (95% UI 0·911–1·71) deaths attributable to bacterial AMR. At the regional level, we estimated the all-age death rate attributable to resistance to be highest in western sub-Saharan Africa, at 27·3 deaths per 100 000 (20·9–35·3), and lowest in Australasia, at 6·5 deaths (4·3–9·4) per 100 000. Lower respiratory infections accounted for more than 1·5 million deaths associated with resistance in 2019, making it the most burdensome infectious syndrome. The six leading pathogens for deaths associated with resistance (Escherichia coli, followed by Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa) were responsible for 929 000 (660 000–1 270 000) deaths attributable to AMR and 3·57 million (2·62–4·78) deaths associated with AMR in 2019. One pathogen–drug combination, meticillin-resistant S aureus, caused more than 100 000 deaths attributable to AMR in 2019, while six more each caused 50 000–100 000 deaths: multidrug-resistant excluding extensively drug-resistant tuberculosis, third-generation cephalosporin-resistant E coli, carbapenem-resistant A baumannii, fluoroquinolone-resistant E coli, carbapenem-resistant K pneumoniae, and third-generation cephalosporin-resistant K pneumoniae.

"Interpretation: To our knowledge, this study provides the first comprehensive assessment of the global burden of AMR, as well as an evaluation of the availability of data. AMR is a leading cause of death around the world, with the highest burdens in low-resource settings. Understanding the burden of AMR and the leading pathogen–drug combinations contributing to it is crucial to making informed and location-specific policy decisions, particularly about infection prevention and control programmes, access to essential antibiotics, and research and development of new vaccines and antibiotics. There are serious data gaps in many low-income settings, emphasising the need to expand microbiology laboratory capacity and data collection systems to improve our understanding of this important human health threat."

***********

Earlier:

Wednesday, July 15, 2020